Related references
Note: Only part of the references are listed.AMP-activated protein kinase activation primes cytoplasmic translocation and autophagic degradation of the BCR-ABL protein in CML cells
Daisuke Koyama et al.
CANCER SCIENCE (2021)
Bone marrow stromal cell-mediated degradation of CD20 leads to primary rituximab resistance in mantle cell lymphoma
Yoshiaki Kuroda et al.
LEUKEMIA (2021)
Proteasome Inhibitor Drugs
Lloyd D. Fricker
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)
A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphoma
Hun J. Lee et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
To Eat or to Die: Deciphering Selective Forms of Autophagy
Alibek Abdrakhmanov et al.
TRENDS IN BIOCHEMICAL SCIENCES (2020)
Mantle cell lymphoma
Sergio Cortelazzo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma
Mojgan Djavaheri-Mergny et al.
CELLS (2019)
Leukemic Non-nodal Mantle Cell Lymphoma: Diagnosis and Treatment
Akriti Gupta Jain et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma
Atish Mohanty et al.
BLOOD (2019)
Mantle cell lymphoma and its management: where are we now?
Abdullah Ladha et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2019)
Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
Rebecca Mitchell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
Rebecca Mitchell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Autophagy regulates apoptosis by targeting NOXA for degradation
Jingchao Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA
Simon Heine et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Bortezomib-based chemotherapy in mantle cell lymphoma
Simon Rule
LANCET ONCOLOGY (2018)
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study
Tadeusz Robak et al.
LANCET ONCOLOGY (2018)
SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma
Patricia Balsas et al.
BLOOD (2017)
TG2 and NF-κB Signaling Coordinates the Survival of Mantle Cell Lymphoma Cells via IL6-Mediated Autophagy
Han Zhang et al.
CANCER RESEARCH (2016)
Purine Analog-Like Properties of Bendamustine Underlie Rapid Activation of DNA Damage Response and Synergistic Effects with Pyrimidine Analogues in Lymphoid Malignancies
Nobuya Hiraoka et al.
PLOS ONE (2014)
Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles' heel in mantle cell lymphoma
M. A. Dengler et al.
CELL DEATH & DISEASE (2014)
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma
Peter M. Voorhees et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Alkylating agents induce histone H3K18 hyperacetylation and potentiate HDAC inhibitor-mediated global histone acetylation and cytotoxicity in mantle cell lymphoma
N. Hiraoka et al.
BLOOD CANCER JOURNAL (2013)
Treatment-Induced Oxidative Stress and Cellular Antioxidant Capacity Determine Response to Bortezomib in Mantle Cell Lymphoma
Marc A. Weniger et al.
CLINICAL CANCER RESEARCH (2011)
Notch Ligands Expressed by Follicular Dendritic Cells Protect Germinal Center B Cells from Apoptosis
Sun-Ok Yoon et al.
JOURNAL OF IMMUNOLOGY (2009)
ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells
Qiuyan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma
Richard I. Fisher et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Combination of hTERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential
T Mori et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells
Y Kawano et al.
BLOOD (2003)
Share Paper
